Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 1 6Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 8Recruiting 3Terminated 2Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1Breast 1

Conditions

Liver Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Terminated × Magnetic Resonance Imaging × Clear all
NCT05009979 2025-08-28

18F-DCFPyL PET/CT in Hepatocellular Carcinoma

National Institutes of Health Clinical Center (CC)

Phase 2 Terminated
8 enrolled 14 charts
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT02317783 2024-11-20

Amyloid Plaque Deposition in Chemotherapy-Induced Cognitive Impairment

University of Utah

Phase 2 Terminated
15 enrolled 6 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡